Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: 1st, Biontech, Biosyngen, Carina, Casi, Eli Lilly, Jacobio, Moderna, Pfizer, Recce, Remegen.